Category Archives: Actos

Featured Stories

First Bard Avaulta Transvaginal Mesh Lawsuit Scheduled for February Trial in MDL

The first test trials in the federal C.R. Bard Avaulta transvaginal mesh litigation will most likely start next year, according to a report from Bloomberg News. About 600 lawsuits involving Bard Avaulta transvaginal mesh products are currently pending in the multidistrict litigation underway Charleston, West Virginia. U.S. District Judge Joseph ...

Read More

FDA Questions Device Makers about Duodenoscope Cleaning Procedures

Following Deadly Outbreaks, FDA Questions Device Makers about Duodenoscope Cleaning Procedures

In light of a recent outbreak linked to contaminated duodenoscopes, the U.S. Food and Drug Administration (FDA) is questioning manufacturers about their methods for cleaning the devices, the New York Times reports. The specialized scopes, which have been linked to several outbreaks in recent years, most recently infected seven patients ...

Read More

Metal-on-Metal Hip Implant Lawyer Takes Issue with Statements Made by DePuy Orthpaedics Official During FDA Meeting

An attorney with a national law firm that represents victims of alleged metal-on-metal hip implant injuries has expressed dismay at some statements made last week regarding the regulation of all-metal hip replacement devices by an official with DePuy Orthopaedics. According to Daniel Burke, Senior Litigation Counsel at Parker ...

Read More

Decision on Pradaxa Bleeding Lawsuit Multidistrict Litigation Expected Soon

Victims of alleged Pradaxa injuries are awaiting word on whether their lawsuits will be consolidated in a multidistrict litigation. According to a report from The Madison Record, so far just over two dozen Pradaxa bleeding lawsuits have been filed in federal courts throughout the U.S.

Read More

Federal DePuy ASR Hip Implant Trials Likely to Start This Year

It looks as though the first trials in the DePuy ASR hip implant multidistrict litigation could begin sometime later this year. According to a report from Bloomberg News, during a status conference held yesterday in Florida, attorneys for both plaintiffs and the defense told U.S. District Judge David Katz that ...

Read More

Smith & Nephew Recalls Metal-on-Metal Hip Implant Component

Medical device maker, Smith & Nephew, just issued a recall for a metal-on-metal hip implant component, a part of one of its all-metal hip replacement systems.

Read More

Canadian Study Confirms Actos Bladder Cancer Risk

A new study conducted by Canadian researchers has found that users of the type 2 diabetes drug, Actos (pioglitazone), may face a higher risk of developing bladder cancer than first thought. The study, published in the British Medical Journal, found that taking Actos for two years doubles the likelihood ...

Read More

Medtronic Sprint Fidelis Leads Vulnerable to Fracture after ICD Switch

Medtronic Sprint Fidelis leads are vulnerable to fracture following ICD switch, says a new study published in the June issue of the journal Heart Rhythm.

Read More

Hip Replacement, Knee Implant Patients with Diabetes, Other Health Problems May Face Difficult Recoveries

Patients receiving hip replacement devices or knee implants may face a more complicated recovery if they are obese, or suffer from diabetes or other health woes. According to a new study published online in the journal Anesthesiology, at least 3% of all total hip or knee replacement patients will ...

Read More

Johnson & Johnson Facing More Metal-on-Metal Hip Implant Woes, as DePuy Pinnacle Complaints Rise

Having already spent around $3 billion on its DePuy Orthopaedics ASR hip implant recall, Johnson & Johnson is facing another potential debacle involving a metal-on-metal version of its Pinnacle Hip Replacement System. According to a report from Reuters, Johnson & Johnson and its DePuy unit already face some 1,600 metal-on-metal ...

Federal Jury Awards $9 Billion in Damages in Actos Bladder Cancer Case

After deliberating for about four hours yesterday, a federal jury ordered Takeda Pharmaceuticals and Eli Lilly & Co. to pay a combined $9 billion in punitive damages to Terrence Allen, finding that the drug makers hid the bladder cancer risks … Continue reading

Posted in Actos, Health Concerns, Legal News, Pharmaceuticals |

Actos Jury Advised Takeda Officials Hid Cancer Risks

actos-hid-cancer-risk-jury-told

The federal trial that just started and involving Actos, Takeda Pharmaceutical Co.’s Type II diabetes drug, includes allegations that Takeda hid risks associated with Actos from physicians and consumers. The litigation accuses Takeda of hiding risks associated with Actos. Because … Continue reading

Posted in Actos, Pharmaceuticals |

First Bellwether Trial in Actos Multidistrict Litigation Underway

actos-litgation-begins

The first federal bellwether trial alleging that the diabetes drug Actos (pioglitazone) caused bladder cancer begins today. The trial is taking place in the U.S. District Court for the Western District of Louisiana before the Honorable Rebecca F. Doherty. The plaintiffs … Continue reading

Posted in Actos, Health Concerns, Legal News, Pharmaceuticals |

Jury Selection Completed in First Actos Bladder Cancer Bellwether Trial

actos-lawsuit-trial-jury-selection

Jury selection was completed on Monday, January 27 in the first bellwether case in the Actos bladder cancer litigation. After pretrial matters January 30, testimony will begin February 3, with the trial expected to last six weeks. This case was … Continue reading

Posted in Actos, Health Concerns, Legal News, Pharmaceuticals |

Actos Maker, Takeda, Hid Drug’s Risks from Patients, Doctors

takeda_hid_actos_risks

Another Actos lawsuit alleges that Takeda Pharmaceutical Co., the maker of the Type 2 diabetes drug, put profits before patient safety and “duped” patients. The lawsuit states that Takeda should be held liable in the cancer death of a former … Continue reading

Posted in Actos, Legal News, Pharmaceuticals |

Florida Man Alleges Serious Injuries After Taking Diabetes Drug, Actos

florida_actos_bladder_cancer

A Florida man alleges that he developed bladder cancer after taking the Type 2 diabetes drug, Actos (pioglitazone), for nearly seven years. A lawsuit has been filed on behalf of the man and is just one of thousands of lawsuits … Continue reading

Posted in Actos, Pharmaceuticals |

Lawsuit Accuses Actos Makers of Placing Profits Before Patient Safety

actos_profit_over_safety

A lawsuit alleges that Asia’s largest drug maker, Takeda Pharmaceuticals, put profits before patient safety. Actos (pioglitazone), Takeda’s Type 2 diabetes drug, has been at the center of thousands of personal injury lawsuits. Takeda officials were aware, as far back … Continue reading

Posted in Actos, Legal News, Pharmaceuticals |

Another Lawsuit Filed Over Allegations that Actos is Tied to Bladder Cancer

actos-lawsuit-oregon_cancer

Another lawsuit has been filed against the makers of the Type 2 diabetes drug, Actos, over allegations that the medication caused the Oregon man to develop bladder cancer. The lawsuit also alleges that the drug makers were aware of the … Continue reading

Posted in Actos, Legal News, Pharmaceuticals |

Another Actos User Alleges Bladder Cancer Caused by Type 2 Diabetes Drug

new_actos_bladder_cancer_claim

A Florida woman is alleging that taking the Type 2 diabetes drug, Actos (pioglitazone), caused her to develop bladder cancer, according to a lawsuit brought against the maker of the drug, Takeda Pharmaceuticals. The woman began taking Actos from about … Continue reading

Posted in Actos, Legal News, Pharmaceuticals |

Gum Disease Tied to Increased Diabetes Risk, May Lead to Increased Risks Tied to Some Type 2 Diabetes Drugs

gum_disease_linked_to_diseases

The links between dental disease and other diseases have been growing, for instance dental disease has been tied to increased risks for developing diabetes and heart disease; pregnancy complications; and, potentially, dementia. Type 2 diabetes is typically treated with any … Continue reading

Posted in Actos, Byetta Cancer, Pharmaceuticals |

© 2005-2018 Parker Waichman LLP ®. All Rights Reserved.